σ receptor antagonists block the development of sensitization to cocaine

European Journal of Pharmacology

Volumn 296, Issue 2, 1996, Pages 123-128

  Ujike, Hiroshi ^a,b   Kuroda, Shigetoshi ^a   Otsuki, Saburo ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NIDA Addiction Research Center   (United States)

Author keywords

Behavioral sensitization; BMY 14802; Cocaine; Schizophrenia; SR 31742A; Receptor

Indexed keywords

1 (3 CHLORO 4 CYCLOHEXYLPHENYL) 3 (HEXAHYDRO 1 AZEPINYL)PROPENE; 1 [3 (3 CHLORO 4 CYCLOHEXYLPHENYL)ALLYL]HEXAHYDROAZEPINE; ALPHA (4 FLUOROPHENYL) 4 (5 FLUORO 2 PYRIMIDINYL) 1 PIPERAZINEBUTANOL; COCAINE; OPIATE ANTAGONIST; PSYCHOSTIMULANT AGENT; RIMCAZOLE; SIGMA OPIATE RECEPTOR; SIGMA OPIATE RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ABSTINENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; HYPERACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RAT; SCHIZOPHRENIA; SNIFFING; STEREOTYPY;

ANIMALS; ANTIPSYCHOTIC AGENTS; AZEPINES; BEHAVIOR, ANIMAL; COCAINE; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SIGMA;

EID: 0029670662     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00693-1     Document Type: Article

References (29)

1. Bellville, J.W. and W.H. Forrest, 1968, Respiratory and subjective effects of d- and l-pentazocine, Clin. Pharmacol. Ther. 9, 142.
2. 1A receptor, Eur. J. Pharmacol. 204, 21.
3. Ellinwood, E.H., A. Sudilovski and L.J. Nelson, 1973, Evolving behavior in the clinical and experimental amphetamine (model) psychosis, Am. J. Psychiat. 34, 1088.
4. Ferris, C.D., D.J. Hirsch, B.P. Brooks and S.H. Snyder, 1991, Sigma receptors: from molecule to man, J. Neurochem. 57, 729.
5. Gewirtz, G.R., J.M. Gorman, J. Volavka, J. Macaluso, G. Gribkoff, D.P. Taylor and R. Borison, 1994, BMY 14802, a sigma receptor ligand for the treatment of schizophrenia, Neuropsychopharmacology 10, 37.
6. Kuczenski, R. and N.J. Leith, 1981, Chronic amphetamine: is dopamine a link in or a mediator of the development of tolerance and reverse tolerance?, Pharmacol. Biochem. Behav. 15, 405.
7. Largent, B.L., A.L. Gundlach and S.H. Snyder, 1984, Psychotomimetic opiate receptors labeled and visualized with (+)-[3H]3-3(3-hydroxyphenyl)-N-(1-propyl)piperidine, Neurobiology 81, 4983.
8. Largent, B.L., H. Wikstrom, A.M. Snowman and S.H. Snyder, 1988, Novel antipsychotic drugs share high affinity for sigma receptors, Eur. J. Pharmacol. 155, 345.
9. Menkel, M., P. Terry, M. Pontecorvo, J.L. Katz and J.M. Witkin, 1991, Selective sigma ligands block stimulant effects of cocaine, Eur. J. Pharmacol. 201, 251.
10. Poncelet, M., V. Santucci, R. Paul, C. Gueudet, S. Lavastre, J. Guitard, R. Steinberg, J.P. Terranova, J.C. Breliere, P. Soubrie and a. 1. et, 1993, Neuropharmacological profile of a novel and selective ligand of the sigma site: SR 31742A, Neuropharmacology 32, 605.
11. Post, R.M., 1975, Cocaine psychosis: a continuum model, Am. J. Psychiat. 132, 231.
12. Post, R.M., 1977, Progressive changes in behavior and seizures following chronic cocaine administration: relationship of kindling and psychosis, in: Cocaine and Other Stimulants, eds. E.H. Ellinwood and M.M. Kilbey (Plenum, New York) p. 353.
13. Reynolds, G.P., J.E. Brown and D.N. Middlemiss, 1991, [3H]ditolylguanidine binding to human brain σ sites is diminished after haloperidol treatment, Eur. J. Pharmacol. 194, 235.
14. Robinson, T.E. and J.B. Becker, 1986, Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis, Brain Res. Rev. 396, 157.
15. Sato, M., Y. Numachi and T. Hamamura, 1992, Relapse of paranoid psychotic state in methamphetamine model of schizophrenia, Schizophr. Bull. 18, 115.
16. Sharkey, J., K.A. Glen, S. Wolfe and M.J. Kuhar, 1988, Cocaine binding at sigma receptors, Eur. J. Pharmacol. 149, 171.
17. Su, T.P., 1982, Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain, J. Pharmacol. Exp. Ther. 223, 284.
18. Su, T.P., 1991, Sigma receptors. Putative links between nervous, endocrine and immune systems, Eur. J. Biochem. 200, 633.
19. Taylor, D.P., M.S. Eison, S.L. Moon and F.D. Yocca, 1991, BMY 14802: a potential antipsychotic with selective affinity for σ-binding sites, in: Advances in Neuropsychiatry and Psychopharmacology, Schizophrenia Research, Vol. 1, eds. C.A. Tamminga and S.C. Schulz (Raven Press, New York) p. 307.
20. Tella, S.R., 1994, Differential blockade of chronic versus acute effects of intravenous cocaine by dopamine receptor antagonists, Pharmacol. Biochem. Behav. 48, 151.
21. Ujike, H., T. Onoue, K. Akiyama, T. Hamamura and S. Otsuki, 1989, Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization, Psychopharmacology 98, 89.
22. Ujike, H., A. Kanzaki, K. Okumura, K. Akiyama and S. Otsuki, 1992a, Sigma (σ) antagonist BMY 14802 prevents methamphetamine-induced sensitization, Life Sci. 50, PL-129.
23. Ujike, H., K. Okumura, Y. Zushi, K. Akiyama and S. Otsuki, 1992b, Persistent supersensitivity of σ receptors develops during repeated methamphetamine treatment, Eur. J. Pharmacol. 211, 323.
24. Ujike, H., K. Tsuchida, K. Akiyama and S. Otsuki, 1992c, Supersensitivity of σ receptors after repeated administration of cocaine, Life Sci. 51, PL-31.
25. Wadenberg, M.L. and S. Ahlenius, 1991, Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychiatric-like effects without catalepsy, J. Neural Transm. 83, 43.
26. Walker, J.M., W.D. Bowen, F.O. Walker, R.R. Matsumoto, C.B. De and K.C. Rice, 1990, Sigma receptors: biology and function, Pharmacol. Rev. 42, 355.
27. Weber, E., M. Sonders, M. Quarum, S. McLean, S. Pou and J.F. Keana, 1986, 1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs, Proc. Natl. Acad. Sci. USA 83, 8784.
28. Weiss, S.R., R.M. Post, A. Pert, R. Woodward and D. Murman, 1989, Context-dependent cocaine sensitization: differential effect of haloperidol on development versus expression, Pharmacol. Biochem. Behav. 34, 655.
29. Weissman, A.D., M.F. Casanova, J.E. Kleinman, E.D. London and S.E. De, 1991, Selective loss of cerebral cortical sigma, but not PCP binding sites in schizophrenia, Biol. Psychiatry 29, 41.